Webinars

Discusses challenges and strategies for high-concentration biologic formulations

Addresses challenges of high-concentration SubQ formulations, especially protein aggregation.

Focuses on developing stable, manufacturable highly concentrated liquid protein formulations.

Explores how strategic formulation enhances biosimilar quality, stability, and market edge.

Introduces "ExPreSo": a data science tool combining formulation expertise and machine learning.

Highlights early developability assessments for successful biotherapeutic clinical and commercial progression.

Examines how early formulation and characterization are key to faster, safer drug development.

Innovative formulations to stabilize lyophilized oncolytic viruses, overcoming deep-frozen challenges.

Presents strategies for dry-state stabilization of enveloped viruses.

Covers essential analytical tools for AAV drug product stability assessment.

Outlines fundamental principles and strategies for effective formulation development.